Европейски съюз - португалски - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - imunologias para aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Европейски съюз - португалски - EMA (European Medicines Agency)

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - imunológicos para suidae - suínos (para engorda) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

Европейски съюз - португалски - EMA (European Medicines Agency)

orion corporation - tasipimidine sulfate - other hypnotics and sedatives - cães - alleviation of situational anxiety and fear in dogs triggered by e. travel, noise, owner departure, veterinary visits.

Европейски съюз - португалски - EMA (European Medicines Agency)

ptc therapeutics international limited - eladocagene exuparvovec - metabolismo de aminoácidos, erros nascidos - enzymes, other alimentary tract and metabolism products - upstaza is indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of aromatic l amino acid decarboxylase (aadc) deficiency with a severe phenotype (see section 5.

Европейски съюз - португалски - EMA (European Medicines Agency)

theramex ireland limited - linzagolix choline - leiomioma - hormonas e análises pituitárias e hipotalâmicas - yselty is indicated for the treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.

Португалия - португалски - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

ratiopharm - comércio e indústria de produtos farmacêuticos, lda. - buprenorfina - comprimido sublingual - 0.4 mg - buprenorfina, cloridrato 0.43 mg - buprenorphine - genérico - duração do tratamento: longa duração

Португалия - португалски - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

fresenius kabi pharma portugal, lda. - cloreto de potássio + glucose - solução para perfusão - 1.5 mg/ml + 50 mg/ml - cloreto de potássio 1.5 mg/ml ; glucose mono-hidratada 55 mg/ml - electrolytes with carbohydrates - genérico - duração do tratamento: curta ou média duração

Португалия - португалски - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

generis farmacêutica, s.a. - buprenorfina - comprimido sublingual - 2 mg - buprenorfina, cloridrato 2.16 mg - buprenorphine - genérico - duração do tratamento: longa duração

Португалия - португалски - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

generis farmacêutica, s.a. - buprenorfina - comprimido sublingual - 8 mg - buprenorfina, cloridrato 8.64 mg - buprenorphine - genérico - duração do tratamento: longa duração

Португалия - португалски - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

fresenius kabi pharma portugal, lda. - cloreto de potássio + cloreto de sódio - solução para perfusão - 3 mg/ml + 9 mg/ml - cloreto de sódio 9 mg/ml ; cloreto de potássio 3 mg/ml - electrolytes - genérico - duração do tratamento: curta ou média duração